On February 22, 2021 Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, reported that members of its management team will participate in panel discussions and present a corporate overview at upcoming investor conferences. Details are as follows (Press release, Syros Pharmaceuticals, FEB 22, 2021, View Source [SID1234575383]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen and Company 41st Annual Health Care Conference
Date: Monday, March 1
Panel Title: Novel Oncology Targets
Panel Time: 1:20 p.m. ET

33rd Annual Roth Conference
Date: Monday, March 15
Panel Title: Navigating Clinical Development in RARE Hematologic & Inflammatory Disease
Panel Time: 10:00 a.m. ET

Oppenheimer 31st Annual Healthcare Conference
Date: Tuesday, March 16
Presentation Time: 8:40 a.m. ET

Live webcasts of the Roth and Oppenheimer presentations will be available on the Investors & Media section of the Syros website at www.syros.com. Archived replays of the webcasts will be available for approximately 30 days following each presentation.